Skip to main content
Access Resources

MJFF Publications

2011 - 2020 of 7461 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • OPEN
    Title: Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo‐Controlled Trial of Rasagiline
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28838
    Citation Count: 6
  • OPEN
    Title: Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106976
    Citation Count: 6
  • RESTRICTED
    Title: Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2021.174452
    Best OA location URL:
    Citation Count: 7
  • RESTRICTED
    Title: Facial Landmark Tracking in Videos of Individuals with Neurological Impairments: Is There a Trade-off Between Smoothness and Accuracyƒ
    Journal Name: 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/embc46164.2021.9630639
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings
    Journal Name: Neuromuscular Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nmd.2021.09.010
    Citation Count: 11
  • OPEN
    Title: Genome-wide association study and functional validation implicates JADE1 in tauopathy
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-021-02379-z
    Citation Count: 17
  • OPEN
    Title: Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways
    Journal Name: Free Radical Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2021.08.230
    Citation Count: 11
  • OPEN
    Title: IL-10: A possible immunobiological component of positive mental health in refugees
    Journal Name: Comprehensive Psychoneuroendocrinology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cpnec.2021.100097
    Citation Count: 2
  • RESTRICTED
    Title: Increased functional connectivity in a population at risk of developing Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026
    Best OA location URL:
    Citation Count: 3
  • RESTRICTED
    Title: Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.010
    Best OA location URL:
    Citation Count: 6
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.